Site Selection magazine
twitter linkedIn facebook email email
In The Formula Changes, you'll learn the latest on what Law 154 might mean for the biopharma industry in Puerto Rico, and what might still be done about it.

Dr. Philippe Pouletty, general partner of Truffle Capital and honorary chairman of France Biotech, offers his observations on the Keys to Europe's Biotech Future.

Indiana's life sciences sector experienced a robust 2010 with companies committing to create more than 4,000 jobs, we learn in Medical Device Momentum.


A U.K.-based life sciences services company, EvaluatePharma, selected the life sciences hub of Boston for its U.S. headquarters. The company's recent opening culminated two years of recruiting by the LifeTech Boston program.

Commercial real estate firm Richards Barry Joyce & Partners has released "bioSTATus - Winter 2011", the firm's semi-annual research publication highlighting Greater Boston's biotechnology real estate market.

The report says the region's biotechnology real estate market is very strong. Vacancy rates for laboratory space have dropped during the two-quarter reporting period, from 13.3 percent to 11.7 percent. Read the report in pdf form here.

New York City officials are seeking responses from a university, applied science organization or related institution to develop and operate an applied sciences research facility in the city. Two of the potential sites are on hospital campuses.

Also, in New York, the Alexandria Center for Life Sciences has opened on Manhattan's east side. It is the first of three buildings to be developed as part of Alexandria's newest life sciences cluster campus.

EuropaBio convened an industry-wide gathering in December to assess the importance of the biotech sector to Europe's economy. Here is a look at their conclusions

A recent poll by Biofuels Digest and the BIO organization pinpoints the predicted economic drivers for bioenergy and bioprocessing in 2011. U.S. military interest in domestic sources of biofuel figures to be among the trends.

A recent PricewaterhouseCoopers report states that the relationship between the U.S. Food & Drug Administration and the life sciences industry is strained. The report offers feedback from 50 life sciences companies.


Vol.1 , Issue 10

Connect with Site Selection
twitter twitter email linkedIn

Most Popular Articles

Site Selection online is a worldwide service of Conway, Inc. ©1983-2018, all rights reserved.
Data is from many sources and not warranted to be accurate or current.
To unsubscribe from our print magazine, contact Julie Clarke. For general inquiries, visit our contact page.
For technical inquiries contact the Webmaster.